Rtw Investments, LP 89bio, Inc. Transaction History
Rtw Investments, LP
- $5.99 Billion
- Q2 2024
A detailed history of Rtw Investments, LP transactions in 89bio, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 7,378,548 shares of ETNB stock, worth $55.2 Million. This represents 0.99% of its overall portfolio holdings.
Number of Shares
7,378,548
Previous 7,378,548
-0.0%
Holding current value
$55.2 Million
Previous $85.9 Million
31.19%
% of portfolio
0.99%
Previous 1.38%
Shares
2 transactions
Others Institutions Holding ETNB
# of Institutions
157Shares Held
107MCall Options Held
65KPut Options Held
1.2M-
Ra Capital Management, L.P. Boston, MA14.2MShares$106 Million1.71% of portfolio
-
Janus Henderson Group PLC London, X013.3MShares$99.3 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.03MShares$60.1 Million2.69% of portfolio
-
Bvf Inc San Francisco, CA7.57MShares$56.6 Million1.85% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$52.5 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $348M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...